by Intravenous solutions offer an indispensable means of ensuring patients obtain necessary hydration and nutrients, especially in situations where oral administration is not viable. These solutions provide vital fluids, electrolytes, vitamins and minerals directly into the bloodstream. They are frequently used in hospitals to treat conditions requiring intravenous therapy such as dehydration, malnutrition, diabetes, gastroenteritis and various others. Aging populations that are more susceptible to chronic diseases have increased the demand for intravenous solutions over the years. With a higher prevalence of lifestyle diseases and complex surgeries, intravenous treatment methods are becoming increasingly important around the world.
The global Intravenous Solutions Market is estimated to be valued at US$ 665.66 Bn in 2024 and is expected to exhibit a CAGR of 4.5% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
One of the key trends driving growth in the Global Intravenous Solutions Market Size is the introduction of advanced formulations to address specific health conditions more effectively. For instance, customized total parenteral nutrition solutions are being devised for conditions like short bowel syndrome. To reduce costs and risks of contamination, single-dose flexible plastic pouches are replacing traditional glass bottles for intravenous fluids. Another notable trend is the rising demand for prefilled intravenous solutions owing to benefits like accurate dosing and lower chances of dosing errors. With the proliferation of chronic diseases, disease-specific intravenous fluids are also gaining traction in the market. More efficient and customizable intravenous solutions options will continue expanding market opportunities going forward.
Porter’s Analysis
Threat of new entrants: Low barriers to entry pose a moderate threat of new entrants in the market. However, established brands, strong distribution networks, and economies of scale enjoyed by major players pose barriers.
Bargaining power of buyers: Buyers have moderate bargaining power due to the availability of substitutes and established presence of several intravenous solution providers.
Bargaining power of suppliers: Suppliers have moderate bargaining power due to their specialized skills, however established players source raw materials from multiple suppliers limiting the power of individual suppliers.
Threat of new substitutes: Availability of alternative modes of drug administration like oral and topical poses a minor threat of substitutes. However, the criticality of IV solutions in acute cares and hospitals limits this threat.
Competitive rivalry: The market has high competitive rivalry owing to established presence of Amcor plc, Bemis Company Inc., Sonoco Products Company and Sealed Air Corporation.
Key Takeaways
The global Intravenous Solutions market is expected to witness high growth over the forecast period of 2024 to 2031.
Regional analysis: North America dominates the global intravenous solutions market and is expected to retain its dominance over the forecast period due to established healthcare facilities and infrastructure as well as prevalence of chronic diseases like cancer and diabetes in the region.
Key players operating in the Intravenous Solutions market include Amcor plc, Bemis Company Inc. (acquired by Amcor), Sonoco Products Company, Sealed Air Corporation, and DS Smith Plc. Key players operating in the intravenous solutions market are focused on expanding their regional presence through acquisitions and partnerships with local players. For instance, in 2019, Amcor acquired Bemis Company Inc. to become a global leader in packaging solutions.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
